Saving changes...



Improving the safety of compounded sterile preparations

Improving the safety of compounded sterile preparations

Improving the safety of compounded sterile preparations

Veterinary Cancer Society
Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association


$25.00 $ 25.00 $ 25.00

25.00 $ 25.00 25.00 25.00
Normal Price: FREE $25.00


Launch date: 14 Jan 2016
Expiry Date:

Last updated: 13 Aug 2018

Reference: 161835

TIming: null

Maximum Attendees:

Places Left: 0

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.


Improving the Safety of Compounded Preparations - Hazardous Drug Compounding – Proposed USP <800> Requirements This session will highlight the essential safety and regulatory requirements of the compounding of Hazardous Drugs. The proposed USP General Chapter <800> will be discussed and practical compliance strategies will be discussed. Patient, Personnel, and Environmental perspectives will be discussed, with emphasis on the global landscape of clinical practice with these agents.


Management Personnel-
o Evaluate your current HD program.
o Identify key characteristics of fully compliant HD employee training program.
o Describe the components and strategies available which can protect all compounding and administration personnel in handling HDs.
o Outline three major characteristics of a fully compliant HD compounding location / physical plant.
o Describe the critical characteristics of a compliant HD drug storage plan.
o Describe the major characteristics of a comprehensive HD cleaning process.
o Describe the characteristics of a fully compliant personnel HD training program.
Veterinary Cancer Society

Author Information Play Video Bio

Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

"Lou Diorio, RPh- Is a principal of LDT Health Solutions, Inc. (LDT) a medication safety & quality management consulting company with over 40 years of pharmacy expertise serving clients nationwide.

Lou is a graduate of Long Island University’s Schwartz College of Pharmacy. Lou is an adjunct Professor of Pharmacy Practice for the college and a preceptor of pharmacy students. Lou is a member of the College’s Alumni Executive Board. Lou has extensive experience in IV and extemporaneous compounding, and lectures, writes, and consults on these topics; LDT lends it expertise to many State Boards of Pharmacy (NY, NJ, UT, MS, SC) and is a nationally recognized subject matter expert. He has managed an FDA-registered cGMP manufacturing operation for Coram Healthcare (SoluNet™ LLC).

An active APhA member, Lou is a past Chair of APhA’s APPM Academy of Practice and Management, an APhA Fellow and is the 2015-2016 Chair of APhA’s Compounding Special Interest Group (SIG). He is also an active member of the Kappa Psi Pharmaceutical Fraternity Foundation Board of Directors.

Since 1985 Lou has practiced in many clinical settings fulfilling many roles, including Chief Operating Officer of Hebrew Hospital Corporate services, a multi-centered sub-acute and LTC hospital system in NY. He has also managed & practiced in home-care, hospital, and retail settings.

Mr. Diorio lectures and develops educational materials for Pharma companies on technical, regulatory, and marketing topics.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 0.25 Hours -
    Exam Attempts: 3
    Exam Pass Rate: 60

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:


User Reviews (0)

Go Back


Saving changes...